Australia (AU)

The MyoRobot: A novel automated biomechatronics system to assess voltage/Ca2+ biosensors and active/passive biomechanics in muscle and biomaterials (2018) Haug M, Reischl B, Prölß G, Pollmann C, Buckert T, Keidel C, Schürmann S, et al. Journal article Flow topology of rare back flow events and critical points in turbulent channels and toroidal pipes (2018) Chin C, Vinuesa R, Orlu R, Cardesa J, Noorani A, Schlatter P, Chong MS Conference contribution Extended VHE gamma-ray emission towards SGR1806-20, LBV 1806-20, and stellar cluster Cl*1806-20 (2018) Abdalla H, Abramowski A, Aharonian F, Benkhali FA, Akhperjanian AG, Anguener EO, Arrieta M, et al. Journal article, Original article Deeper HESS observations of Vela Junior (RX J0852.0-4622): Morphology studies and resolved spectroscopy (2018) Abdalla H, Abramowski A, Aharonian F, Benkhali FA, Akhperjanian AG, Andersson T, Anguener EO, et al. Journal article, Original article EX-MET study: Exercise in prevention on of metabolic syndrome - A randomized multicenter trial: Rational and design (2018) Tjonna AE, Ramos JS, Pressler A, Halle M, Jungbluth K, Ermacora E, Salvesen O, et al. Journal article Suicidal Thoughts and Behaviors Among First-Year College Students: Results From the WMH-ICS Project (2018) Mortier P, Auerbach RP, Alonso J, Bantjes J, Benjet C, Cuijpers P, Ebert D, et al. Journal article Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: A Mendelian randomization study (2018) Ong JS, Hwang LD, Cuellar-Partida G, Martin NG, Chenevix-Trench G, Quinn MCJ, Cornelis MC, et al. Journal article ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling (2018) Schmidt S, Schumacher N, Schwarz J, Tangermann S, Kenner L, Schlederer M, Sibilia M, et al. Journal article The SUrvey for Pulsars and Extragalactic Radio Bursts - II. New FRB discoveries and their follow-up (2018) Bhandari S, Keane EF, Barr ED, Jameson A, Petroff E, Johnston S, Bailes M, et al. Journal article Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution